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Modulation of macrophage antitumor potential by
apoptotic lymphoma cells
Jorine JLP Voss1, Catriona A Ford1, Sofia Petrova1, Lynsey Melville1, Margaret Paterson1, John D Pound1, Pam Holland1, Bruno Giotti2,
Tom C Freeman2 and Christopher D Gregory*,1
In aggressive non-Hodgkin’s lymphoma (NHL), constitutive apoptosis of a proportion of the tumor cell population can promote net
tumor growth. This is associated with the accumulation of tumor-associated macrophages (TAMs) that clear apoptotic cells and
exhibit pro-oncogenic transcriptional activation profiles characteristic of reparatory, anti-inflammatory and angiogenic programs.
Here we consider further the activation status of these TAMs. We compare their transcriptomic profile with that of a range of other
macrophage types from various tissues noting especially their expression of classically activated (IFN-γ and LPS) gene clusters –
typically antitumor – in addition to their previously described protumor phenotype. To understand the impact of apoptotic cells on
the macrophage activation state, we cocultured apoptotic lymphoma cells with classically activated macrophages (M(IFN-γ/LPS), also
known as M1, macrophages). Although untreated and M(IFN-γ/LPS) macrophages were able to bind apoptotic lymphoma cells equally
well, M(IFN-γ/LPS) macrophages displayed enhanced ability to phagocytose them. We found that direct exposure of M(IFN-γ/LPS)
macrophages to apoptotic lymphoma cells caused switching towards a protumor activation state (often referred to as M2-like) with
concomitant inhibition of antitumor activity that was a characteristic feature of M(IFN-γ/LPS) macrophages. Indeed, M(IFN-γ/LPS)
macrophages exposed to apoptotic lymphoma cells displayed increased lymphoma growth-promoting activities. Antilymphoma
activity by M(IFN-γ/LPS) macrophages was mediated, in part, by galectin-3, a pleiotropic glycoprotein involved in apoptotic cell
clearance that is strongly expressed by lymphoma TAMs but not lymphoma cells. Intriguingly, aggressive lymphoma growth was
markedly impaired in mice deficient in galectin-3, suggesting either that host galectin-3-mediated antilymphoma activity is required
to sustain net tumor growth or that additional functions of galectin-3 drive key oncogenic mechanisms in NHL. These findings have
important implications for anticancer therapeutic approaches aimed at polarizing macrophages towards an antitumor state and
identify galectin-3 as a potentially important novel target in aggressive NHL.
Cell Death and Differentiation advance online publication, 3 February 2017; doi:10.1038/cdd.2016.132
Tumor-associated macrophages (TAMs) form an integral part
of the microenvironment of many cancers. Despite their innate
antitumor potential, TAMs have been associated with poor
prognosis in most cases and have been shown to adopt anti-
inflammatory, prorepair phenotypes, promoting angiogenesis,
matrix remodeling, tumor growth and metastasis.1,2 TAMs,
however, can engage in antitumor activities, effectively
constraining growth of nascent and of certain established
tumors.3,4 Furthermore, human cancer gene array analyses
reveal macrophage signatures containing, in addition to
tumor-promoting gene activation, potential antitumor path-
ways such as MHC class II antigen presentation and T-cell
costimulation.5 This reflects the plasticity of TAMs in response
to the tumor microenvironment.
TAMs display highly active phagocytic and lipid metabolic
pathways suggestive of their homeostatic activity in the
clearance of dying cells that are constitutively produced
during net tumor growth.5,6 Cell death is often a prominent
feature of malignant disease, tumor growth resulting from
the imbalance between proliferation and death.7 Indeed,
apoptosis and caspase activation have been found to
correlate with aggressive disease in multiple
malignancies,8–13 including ‘starry-sky’ lymphoma6 (classi-
cally Burkitt’s lymphoma, BL) in which TAMs engaged in the
clearance of apoptotic cells appear analogous to stars in a sky
of tumor cells.14,15 Timely and effective clearance of
apoptotic cells by macrophages prevents the release of
potentially toxic or immunogenic intracellular contents from
dying tumor cells, and may contribute to suppression of
inflammation and inhibition of innate and adaptive antitumor
immunity. Engagement with apoptotic tumor cells may also
promote angiogenic and matrix remodeling signaling in TAMs,
extending the known protumor capacities of the apoptotic cell
clearance response.6
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As apoptotic cells can promote oncogenic signaling in
macrophages, we hypothesized that interaction and engulf-
ment of apoptotic tumor cells could help counter potential
antitumor signaling properties of the tumor microenvironment,
biasing the TAM phenotype towards tumor support. Here we
show that starry-sky TAMs (SS-TAMs) from BL xenografts,
previously reported to display an overtly pro-oncogenic
transcriptional activation profile (‘M2-like’),6 also express
genes associated withmacrophages activated by the classical
stimuli, interferon-γ (IFN-γ) and lipopolysaccharide (LPS),
which typically have antitumor activity (M1 activation state).
Such macrophages were found to interact effectively with
apoptotic tumor cells, resulting in switching of activation state
from antitumor to protumor with concomitant suppression of
tumor cell killing activity and promotion of net tumor population
growth.
Results
Characteristics of classically activated macrophages can
be identified in SS-TAMs and other macrophage sub-
types. Given that the core macrophage signature of six large
human cancer data sets contained classically activated
characteristics,5 we further analyzed in situ transcriptomics
data sets of laser-microdissected SS-TAMs from BL xeno-
grafts (as described previously6), seeking signatures of
classical activation. These data provide detailed, unbiased
in situ activation profiles of SS-TAMs, which are actively
engaged in the clearance of apoptotic BL cells. Functional
annotation using the Database for Annotation and Integrated
Discovery (DAVID) of all genes upregulated in SS-TAMs,
compared with germinal center macrophages (GCMs)
revealed that in addition to the previously reported tumor-
promoting pathways,6 genes associated with immune and
inflammatory responses linked to classical activation were
also upregulated (Table 1).
To understand further the activation characteristics of SS-
TAM data sets, we analyzed the transcriptomic profiles of a
range of monocyte and macrophage data sets selected from
the Gene Expression Omnibus (GEO) data repository.
Suitable data sets were used to construct the large networks
shown in Figure 1a. Cluster analysis using the Markov
Clustering (MCL) algorithm5 defined clusters of highly
connected nodes (transcripts), with edges representing the
relationships between the nodes. The main function of each
cluster was assessed using gene functional annotation
analysis and the main function of the transcripts in some of
the largest clusters is indicated. Consistent with the main
observed function of macrophages, and previous findings,16
the largest cluster of genes identified was associated with
Table 1 Selected transcripts associated with classical macrophage activation that are upregulated in SS-TAMs
Gene Protein Fold change P-value
Ifit3 Interferon-induced protein with tetratricopeptide repeats 3 5.8 0.0190023
Ccl8 Chemokine (C–C motif) ligand 8 5.6 0.00193649
Fcgr1 Fc receptor, IgG, high-affinity I 5.5 0.00481987
Ccl3 Chemokine (C–C motif) ligand 3 5.2 0.00108299
Ifit2 Interferon-induced protein with tetratricopeptide repeats 2 5.1 0.00354699
Tlr13 Toll-like receptor 13 4.3 0.0328242
Tlr4 Toll-like receptor 4 4.3 0.0010059
Tlr8 Toll-like receptor 8 4.0 0.000454208
Fcer1g Fc receptor, IgE, high-affinity I, γ polypeptide 3.8 0.000129844
Ccl12 Chemokine (C–C motif) ligand 12 3.8 0.024655
Fcgr3 Fc receptor, IgG, low-affinity III 2.3 0.0113843
Ifitm2 Interferon-induced transmembrane protein 2 2.3 0.0221287
Irf7 Interferon regulatory factor 7 2.1 0.0395954
Tlr2 Toll-like receptor 2 2.1 0.00388199
Ccl7 Chemokine (C–C motif) ligand 7 2.1 0.000652815
Fcgrt Fc receptor, IgG, α-chain transporter 2 0.00946608
Ccl2 Chemokine (C–C motif) ligand 2 2 0.0113823
Abbreviations: DAVID, Database for Annotation and Integrated Discovery; GCM, germinal center macrophage; SS-TAM, starry-sky TAM; TAM, tumor-associated
macrophage
Functional annotation using DAVID revealed that multiple transcripts associated with classically activated macrophages are upregulated by SS-TAMs, as compared
with GCMs. Upregulated genes and fold change compared with GCMs are shown here. Data are from three animals. SS-TAMs were from BL2 xenografts and all
transcriptional profiles were derived from laser capture-microdissected macrophages (see Materials and Methods)
Figure 1 Characteristics of classically activated macrophages can be identified in SS-TAMs and other macrophage subtypes. Ninety samples, representing 29 mouse
macrophage and monocyte populations from 6 individual studies were normalized and the tool BioLayout Express3D was used to calculate pairwise Pearson's correlation
coefficients for every transcript represented on the array. A network graph was constructed using a cutoff of r= 0.8, where nodes represent transcripts analyzed on the array, and
edges represent the coexpression relationships between the transcripts. The resultant graph was laid out in three-dimensional space and comprised of 8022 nodes (transcripts),
connected by 215 224 edges. The graph was then clustered using the MCL algorithm with an inflation value of 2.2. This resulted in 1061 clusters containing more than five nodes.
(a) The individual nodes (transcripts) in each cluster color-coded, and the functional association of the genes in some of the larger clusters is indicated. (b) Examples of clusters
associated with the activation of macrophages by LPS are shown isolated from the main graph alongside their average expression profile of the transcripts that make up the
cluster. (c) Transcripts that are upregulated by SS-TAM (compared with GCM and LNM) were imported and overlaid onto the macrophage data set network graph shown in (a) and
the main function of some of the larger clusters is indicated
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endocytosis and phagocytosis (Cluster 1). Other large clusters
were found to be associated with other broad biological
processes, including mitochondria, ribosomes and RNA
processing, cell cycle, extracellular matrix, regulation of
differentiation, transcription, proliferation and cell death
(Figure 1a). Interestingly, as with SS-TAMs, LPS and IFN
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response signatures were associated with most macrophages
in the data sets (Figures 1a and b).
Examination of the genes upregulated in SS-TAMs as
compared with GCMs and unstimulated lymph node
macrophages6 showed that many were related to endocytosis
and phagocytosis, the cell cycle and extracellular matrix
clusters (Figure 1c). This is consistent with our previous
findings that SS-TAMs are highly phagocytic towards apopto-
tic tumor cells, have been shown to proliferate in vivo and
upregulate various matrix metalloproteinases.6
Classically activated macrophages have enhanced pha-
gocytic capacity. To understand their impact on the macro-
phage activation state, we studied the interaction of apoptotic
lymphoma cells with classically activated (IFN-γ and LPS)
bone marrow-derived macrophages (BMDMs) in vitro.
Following recent guidelines,17 we refer to these macrophages
here as M(IFN-γ/LPS) macrophages. First, the ability of
M(IFN-γ/LPS) macrophages to bind to and to phagocytose
apoptotic lymphoma cells was investigated. No significant
differences were found in the ability of M(IFN-γ/LPS) macro-
phages to bind to apoptotic lymphoma cells, but a signifi-
cantly larger proportion of M(IFN-γ/LPS) macrophages were
capable of phagocytosing apoptotic lymphoma cells com-
pared with untreated BMDMs (Figures 2a and b).
Exposure of M(IFN-γ/LPS) macrophages to apoptotic
lymphoma cells causes activation switching towards
SS-TAMs. We next investigated whether apoptotic lym-
phoma cells could alter the activation state of M(IFN-γ/LPS)
macrophages from anti- to protumor. To this end, M(IFN-γ/LPS)
macrophages were cocultured with apoptotic lymphoma
cells, and the expression of protumor signatures associated
with SS-TAMs as described previously,6 together with
expression of Il6 and Tnf, markers of M(IFN-γ/LPS) macrophage
activation, were analyzed. Coculture of M(IFN-γ/LPS) macro-
phages with apoptotic lymphoma cells significantly increased
the expression of Mrc1, Timp2, Cd36, Pparg and Gas6,
whereas the expression of Tnf and Il6 were significantly
decreased (Figures 3a–c). Next, we investigated whether
these differences were due specifically to coculture with
apoptotic cells or if coculture with untreated viable lymphoma
cells could produce a similar effect. Additionally, as the
lymphoma cells show relatively high levels of spontaneous
apoptosis (Figure 3d), cocultures were performed with
Bcl-2-transfected lymphoma cells, whose ability to undergo
apoptosis is suppressed.18 The viability of the apoptotic and
viable lymphoma cells at the start and end of the coculture
period is also shown in Figure 3d. As shown in Figure 3e, the
upregulation of Gas6, Mrc1, Cd36 and Timp2 expression
by M(IFN-γ/LPS) macrophages was specific for coculture
with apoptotic cells, as coculture with unstimulated or
Figure 2 Classically activated (M(IFN-γ/LPS)) macrophages have enhanced phagocytic capacity. Untreated and IFN-γ+LPS-stimulated BMDMs were assessed for their ability
to (a) interact with and (b) phagocytose apoptotic BL2 cells in a microscopy-based phagocytosis assay. Data are means± S.E.M. for the percentage of BMDMs demonstrating
interaction (n= 3) or phagocytosis (n= 4) of apoptotic BL2 cells and untreated controls. Statistical analysis was performed using a two-tailed paired t-test. ***Po0.001
Figure 3 Exposure of M(IFN-γ/LPS) macrophages to apoptotic lymphoma cells causes activation switching towards SS-TAMs. Four-hour IFN-γ+LPS-stimulated BMDMs were
cocultured for 24 h with apoptotic (apo BL2), untreated BL2 (BL2) or untreated Bcl-2-transfected BL2 (BL2-Bcl-2) cells. Apoptosis of the BL2 cells was triggered by 100 mJ/cm2
UVB irradiation. (a–f) mRNA expression of selected genes was assessed following coculture and normalized using the reference genes Tuba1b, Hsp90, Hprt and B2m.
Expression is presented as log2 ratio relative to IFN-γ+LPS-stimulated BMDMs. (a–c) Means± S.E.M. for three to seven independent experiments. The dotted lines at y= 1 and
y=−1 indicate a twofold increase or decrease of expression, respectively. Statistical analysis was performed on raw data for means showing a twofold increase or decrease of
expression, using a two-tailed paired t-test and compared IFNγ+LPS-stimulated C57BL/6 BMDM cultured with or without apoptotic BL2 cells. **Po0.01, ***Po0.001 and
****Po0.0001. (d) Viability of coculture lymphoma cells was assessed by AxV/PI staining at the beginning of coculture (T0) and at the end of coculture (Tend). (e) Data are
means± S.E.M. for n= 6 for all treatments, except n= 4 for BL2-Bcl-2 cells. Statistical analysis was performed on the raw data using one-way analysis of variance (ANOVA) with
Dunnett’s multiple comparisons test and is shown compared with IFN-γ- and LPS-stimulated Balb/c BMDM. *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001. (f) Balb/c
BMDM and lymphoma cells were separated by a 0.44 μm membrane during coculture. Data are means± S.E.M. for n= 4 for all treatments and expression of IFN-γ+LPS-
stimulated BMDMs cocultured with apoptotic lymphoma cells is presented as log2 ratio relative to IFN-γ+LPS-stimulated BMDMs alone. Statistical analysis was performed on the
raw data using a two-tailed paired t-test. *Po0.05
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Bcl-2-transfected lymphoma cells did not lead to a significant
upregulation of these genes. Only in the case of Timp2 could
untreated lymphoma cell cultures, of which approximately
half the cells would undergo apoptosis during the course of
the assay (Figure 3d), also upregulate Timp2 expression.
By contrast, Bcl-2-transfected cells could not (Figure 3e).
Apoptosis modulates macrophage antitumor activity
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Pparg was significantly upregulated by coculture with both
apoptotic and viable lymphoma cells, but there appeared to
be a trend of higher upregulation when lymphoma coculture
cells displayed higher levels of apoptosis. Additionally,
downregulation of Tnf was specific for apoptotic, but not
viable, lymphoma cells (Figure 3e). Moreover, untreated and
Apoptosis modulates macrophage antitumor activity
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Bcl-2-transfected lymphoma cells were even capable of
significantly upregulating the expression of Tnf by M(IFN-γ/
LPS) macrophages. Coculture with untreated BL2 cells or
Bcl-2-transfected cells could also significantly decrease
expression of Il6, but a trend towards a greater inhibition
with greater numbers of apoptotic cells was observed
(Figure 3e).
Apoptotic cell-mediated suppression of M(IFN-γ/LPS)
macrophage gene activation is dependent on factors
released from apoptotic cells. Next, we investigated
whether the effects of apoptotic cells on gene expression
by M(IFN-γ/LPS) macrophages was dependent on direct
contact. To this end, M(IFN-γ/LPS) macrophages were cocul-
tured either directly with apoptotic or untreated lymphoma
cells in the same well, or the macrophages and lymphoma
cells were separated by a 0.44 μm pore-size transwell
membrane, which prevents direct intercellular interactions.
No significant differences in expression were observed for
Gas6, Mrc1, Cd36, Pparg or Timp2 between cocultures with
or without the membrane, suggesting that the effects of
coculture with apoptotic cells were due to release of
subcellular material from apoptotic cells (Figure 3f). Further-
more, while expression of Tnf was similarly unaffected by the
separation of M(IFN-γ/LPS) macrophages and apoptotic cells,
expression of Il6 was partially inhibited (Figure 3f), suggest-
ing that maximal apoptotic cell-mediated reduction in Il6
expression by M(IFN-γ/LPS) macrophages results from a
combination of both direct contact with apoptotic cells and
via subcellular material.
Exposure of M(IFN-γ/LPS) macrophages to apoptotic lym-
phoma cells stimulates lymphoma growth. It has long
been known that classically activated macrophages display
antitumor cytotoxic and cytostatic effects19–21 and it has
previously been shown that coculture with apoptotic cells can
reduce the ability of classically activated BMDMs to induce
cell death.22 To determine the effects of apoptotic lymphoma
cell-conditioned M(IFN-γ/LPS) macrophages on the lymphoma
cell-birth/cell-death equation, we designed the protocol
summarized in Figure 4a. Briefly, fluorescently labeled
M(IFN-γ/LPS) macrophages were cocultured with apoptotic or
viable lymphoma cells or media alone. After washing, the
macrophages were cocultured with fluorescently labeled
viable lymphoma target cells, whose viable, early apoptotic
and late apoptotic cell numbers were ultimately assessed as
end points using flow cytometry. The results indicate that,
compared with untreated BMDMs, M(IFN-γ/LPS) macrophages
caused significant reduction in the number of viable target
cells over a 20 h coculture period (Figures 4b and c); target
lymphoma cells underwent apoptosis (Figure 4c and d).
When M(IFN-γ/LPS) macrophages were treated with apoptotic
lymphoma cells (either human or murine) before coculture
with target lymphoma cells, viable target cell numbers were
significantly larger compared with untreated M(IFN-γ/LPS)
macrophages. This was specific for pre-treatment with
apoptotic lymphoma cells, as viable or apoptosis-
suppressed lymphoma cells did not significantly affect target
cell numbers (Figures 4b and c). Interestingly, the total
number of apoptotic and necrotic target cells did not decrease
during the course of the coculture (Figure 4c). These results
suggest that pre-treatment of M(IFN-γ/LPS) macrophages with
apoptotic cells stimulate total tumor cell growth in the face of
cell destruction.
The ability of apoptotic cells to stimulate macrophages
to promote lymphoma cell growth is contact-
dependent. Next, we investigated whether the ability of
M(IFN-γ/LPS) macrophages pre-treated with apoptotic cells to
promote tumor cell growth is contact-dependent. M(IFN-γ/LPS)
macrophages were either pre-treated directly with apoptotic
or untreated BL2 cells, or the two cell types were separated
by a 0.44 μm transwell membrane, preventing direct contact.
The presence of the membrane during pre-treatments of
M(IFN-γ/LPS) macrophages with apoptotic cells significantly
reduced the number of viable target cells present at the end
of the assay (Figure 4e). The total number of apoptotic cells
was not affected (Figure 4f). This indicates that the tumor cell
growth-promoting effects of apoptotic lymphoma cell-treated
M(IFN-γ/LPS) macrophages are dependent on direct contact
between macrophages and apoptotic cells.
Galectin-3 deficiency attenuates antilymphoma activity
by M(IFN-γ/LPS) macrophages. We next attempted to define
further the mechanism underlying the protumor effects of
apoptotic lymphoma cells interacting with antitumor macro-
phages. We reasoned that the protein lectin, galectin-3 may
be active in this context as (1) it is strongly expressed by
macrophages and is involved in apoptotic cell clearance,23
(2) it is upregulated in SS-TAMs,6 (3) it regulates alternative
Figure 4 Exposure of M(IFN-γ/LPS) macrophages to apoptotic lymphoma cells stimulates lymphoma growth. (a) Schematic drawing of macrophage cytotoxicity assay. Balb/c
BMDMs were labeled with a PKH67 fluorescent green marker and then activated with IFN-γ+LPS or left untreated for 4 h, before apoptotic or viable BL2 or BL2-Bcl-2 human
coculture lymphoma cells or apoptotic or viable λ-MYC murine coculture lymphoma cells were added for an additional 24 h. After 28 h total pre-treatment, cocultured cells or
media controls were removed by repeated washing and macrophage cytotoxicity was tested by the addition of BL2 lymphoma target cells that had been labeled with the
fluorescent red membrane marker PKH26 at a 1:1 ratio to BMDMs. Cells were cocultured for 20 h, and at the end of the assay, the viability and number of lymphoma target cells
was assessed by flow cytometry using a ratiometric asymmetry probe in combination with a dead cell stain. (b) Viable or (c) total number of target cells are shown for target cells
cultured alone or cultured in the presence of unstimulated or IFN-γ+LPS-stimulated BMDMs with or without additional pre-treatments with apoptotic or viable lymphoma cells.
Data are mean±S.E.M. for n= 6. Statistical analysis was performed using one-way analysis of variance (ANOVA) with Dunnett’s multiple comparison test and all coculture
samples were compared with IFN-γ+LPS-stimulated BMDMs alone. *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001. (d) DAPI (4′,6-diamidino-2-phenylindole) staining of
lymphoma target cells in untreated and IFN-γ+LPS-stimulated BMDM-target cell cocultures showing coculture with IFN-γ+LPS-stimulated BMDMs led to condensation of the
nuclei of most target cells. (e) Viable target cell counts and (f) total cell counts of untreated BMDMs and IFN-γ+LPS-stimulated cells pre-treated with or without apoptotic or viable
BL2 cells either directly (control) or separated by a 0.44 μm transwell. Data are means+S.E.M. for n= 4. Statistical analysis is shown comparing each of the prestimuli between
with or without transwell using an unpaired t-test and correcting for multiple comparisons using the Holm–Sidak method. *Po0.05
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macrophage activation24 and may therefore contribute to
protumor macrophage activation and (4) we observed during
the present studies that the galectin-3 gene, Lgals3, was
upregulated when M(IFN-γ/LPS) macrophages were cocultured
with apoptotic cells (Figure 3b). Galectin-3-deficient
M(IFN-γ/LPS) macrophages proved to be less effective than
wild-type (WT) counterparts in antilymphoma activity, but
were comparable to WT macrophages in the promotion of
lymphoma growth stimulated by apoptotic tumor cells. Similar
observations were made both with human and murine
lymphoma preparations (Figures 5a and b). These results
suggest that galectin-3 is involved in the control of macro-
phage antitumor activity, but is dispensable for the
lymphoma growth-promoting effects of apoptotic cell-
triggered M(IFN-γ/LPS) macrophages.
Aggressive lymphoma growth is impaired in mice
deficient in galectin-3. Impairment of the antitumor capacity
of galectin-3-deficient M(IFN-γ/LPS) macrophages in vitro sug-
gested that galectin-3 may be important in innate antitumor
immunity in NHL as has been indicated in other models.25,26
Conversely, the upregulation of galectin-3 gene expression in
SS-TAMs may support the argument that galectin-3 imparts
protumor activity. To clarify the potential pro- or antitumor
properties of galectin-3 in NHL, we next determined the effect
of galectin-3 deficiency in the λ-MYC model of aggressive
B-cell lymphoma.6 As shown in Figure 6a, galectin-3-deficient
mice developed tumors less frequently compared with their
WT counterparts. In cases where tumors developed success-
fully in galectin-3 knockout (KO) animals, neither growth rate
nor histological architecture were significantly altered by the
absence of galectin-3 (Figures 6b and c). Note that, in the WT
animals, galectin-3 was expressed prominently by TAMs but
not by lymphoma cells (Figure 6d). Taken together with the
in vitro observations, the general suppression of tumor
growth in the absence of galectin-3 in vivo suggests (1) that
host galectin-3-mediated antilymphoma activity is required to
sustain net tumor growth and/or (2) that additional function(s)
of galectin-3 drive key pro-oncogenic mechanisms in NHL.
Discussion
Here we have considered the inter-relationships of pro- and
antitumor macrophage activities in the context of starry-sky
NHL, an aggressive malignant disease in which apoptosis,
TAMs and apoptotic cell clearance by TAMs are prominent
features. Emerging evidence strongly supports the view that
apoptosis of tumor cells can generate protumor signals that
polarize TAMs towards a protumor phenotype. We recently
showed that protumor TAMs accumulate in starry-sky NHL in
response to apoptosis.6 Given the possibility that the antitumor
potential of TAMs may be harnessed or stimulated for
improved anticancer therapy, we sought to clarify the effects
of apoptotic lymphoma cells on antitumor TAMs.
We were initially interested in determining the extent to
which characteristics of classical macrophage activation –
which is known to lead to antitumor activity – could be
observed in macrophages interacting with apoptotic cells in
the tumor microenvironment. We previously noted that
microdissected TAMs accumulating in starry-sky NHL (SS-
TAMs), defined by their capacity to engulf apoptotic tumor
cells, displayed features of classically activated macrophages
alongside their prominent protumor characteristics.6 Here we
analyzed the classically activated features of SS-TAMs in
more detail and compared these with other monocyte and
macrophage data sets, including alternative TAMs. We found
that the majority of these cell populations exhibited features
typical of the classical IFN/LPS response. This findingmay not
be surprising, given that features of the classical activation
state merely provide descriptive indicators of various states of
macrophage polarization in an activation continuum rather
than definitive activation signatures or lineage paths.27 Thus,
although the classical activation stimulus (IFN-γ and LPS) may
be regarded as prototypically antitumor, some of the char-
acteristics of this polarization may feature as part of the
activation profile of protumor TAMs. In the specific case of SS-
Figure 5 Galectin-3 deficiency attenuates antilymphoma activity by M(IFN-γ/LPS)
macrophages. Mature BMDMs fromWTor Lgals3 KOmice were pre-treated with IFN-
γ+LPS for 4 h before coculture with 10x the number of apoptotic or untreated
lymphoma cells. The ability of the macrophages to kill target lymphoma cells was then
measured by the addition of an equal number of lymphoma cells. Viable target cell
counts (a) and total cell counts (b) of untreated BMDMs and IFN-γ+LPS-stimulated
cells cocultured with or without apoptotic or viable lymphoma cells are shown. Data
are means± S.E.M. for n= 4. Statistical analysis was performed on the raw
data using an unpaired t-test and corrected for multiple comparisons using the
Holm–Sidak method. *Po0.05
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TAMs, these macrophages were found to display multiple
features typical of classically activated, antitumor macro-
phages despite engagement in the clearance of apoptotic
cells, which are known to have reparatory stimulatory
activities,4,28 and which would be expected as a consequence
to provide protumor signals. It is possible that the combination
of seemingly pro- and antitumor features displayed
by SS-TAMs represents the ‘yin and yang’ of the tumor
microenvironment: innate antitumor properties of host
macrophages being tempered by exposure to (apoptotic)
tumor cells (vide infra). In established tumors, this interplay
may stem from the mechanisms through which the antitumor
phenotype of early macrophages is inhibited in nascent
tumors and our observations support the contention that
apoptosis is an important inhibitory effector of such innate
antitumor immunity.
Figure 6 Aggressive lymphoma growth is impaired in mice deficient in galectin-3. Tumor growth in WT C57BL/6 and Lgals3 C57BL/6 KO mice injected with 0.5 × 106 λ-MYC
cells. (a) Kaplan–Meier plot showing killing following tumor growth to 1.44 cm2 (n= 15WTand n= 16 KOmice). ***Po0.001, Mantel-Cox log rank test. (b) When a tumor formed,
the time taken for the tumors to grow to 1.44 cm2±S.E.M. is shown (n= 13 WTand n= 5 KO mice). No statistically significant difference. (c) Representative hematoxylin and
eosin staining of λ-MYC tumors grown in WT (n= 12) or Lgals3 KO (n= 5) mice. (d) Representative galectin-3 immunohistochemistry of λ-MYC tumors grown in WT (n= 12) or
Lgals3 KO (n= 5) mice. Strong staining of galectin-3 in WT tumors is associated with TAMs. Note there is also some indication of possible low-level staining by tumor cells
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In accordance with previous studies, endocytic and phago-
cytic pathways were highly prominent in the transcriptome of
all macrophages, including the SS-TAMs, whose main
phagocytic substrates are apoptotic tumor cells. In the context
of normal tissue turnover, clearance of apoptotic cells is a
homeostatic mechanism, mediated by tissue-resident macro-
phages (as well as non-macrophage phagocytic neighbors)
and known to drive a reparatory, anti-inflammatory phenotype,
for example, in normal germinal centers.6 Here we demon-
strate that classically activated macrophages display
enhanced phagocytosis of apoptotic lymphoma cells
(Figure 2b). Our results suggest that in an inflammatory
context – such as during infection, wounding or in malignant
tissue – classical polarization of macrophage activation would
endow responding macrophages with enhanced capacity to
engulf apoptotic cells.
In addition to switching on their phagocytic program,
macrophages engage in a spectrum of activities in response
to apoptotic cells, which collectively foster the resolution of
inflammation, the sculpting of organs during development, the
promotion of angiogenesis and wound repair. All these
macrophage activities are features of TAMs and indicate that
apoptosis could provide critical signals to control the activation
of macrophages in the tumor microenvironment. Herewe have
extended this notion to show that apoptotic lymphoma cells
dominantly change the activation status of macrophages from
anti- to protumor at the transcriptional level. These findings
accord with previous studies that demonstrated that preincu-
bation with apoptotic cells can increase anti-inflammatory and
decrease proinflammatory signaling by monocytes and
macrophages.29,30 Notably, the transcriptional switching we
observed was, at least in part, independent of direct contact
with apoptotic cells, indicating that these macrophage
responses can be uncoupled from phagocytosis. The under-
lying molecular mechanisms remain to be determined and
may involve the release of intercellular signaling moieties from
the apoptotic cells in soluble and/or membrane-bound,
vesicular forms. These results suggest that the macrophage
response to apoptotic lymphoma cells may extend beyond that
of the immediate phagocyte. Candidate molecules released
from apoptotic cells that are known to signal macrophage
responses include lysophosphatidylcholine, sphingosine-1-
phosphate, fractalkine and ATP,28,31–33 but apoptosis yields a
broadening spectrum of biologically active factors,34 which
could theoretically contribute to the transcriptional switching of
responding macrophages and elucidation of the active
components will require extensive future investigation.
In concert with the changes in activation profile, we found
M(IFN-γ/LPS) macrophages exposed to apoptotic lymphoma
cells to be functionally altered, becoming compromised in their
capacity to kill tumor cells. These observations extend those
reported in a previous study in which apoptotic cells appeared
to reduce cytotoxicity of classically activated macrophages,
although it was previously unclear whether the modulatory
effects of the apoptotic cells resulted from their interaction with
macrophages or with LPS.22 Our results also extend the work
of Evans and Alexander who, as early as 1970, noted that
exposure of lymphoma cells to cytotoxic macrophages
inhibited the latter cells’ ability to exert antitumor effects.35
We were surprised to observe, in addition, that M(IFN-γ/LPS)
macrophages treated with apoptotic lymphoma cells were
endowed with the capacity to promote overall expansion of
lymphoma cell populations. Reflecting the dynamics of
lymphoma growth in starry-sky tumors, cocultures of apoptotic
cell-treated M(IFN-γ/LPS) macrophages displayed net total
population growth in the face of substantial apoptosis
(Figures 4b and c). This effect appeared to be mediated
through cell-to-cell contact, although relatively large
(4400 nm diameter) extracellular vesicles may also have a
role. Thus, macrophages initially exhibiting a classical
antitumor activation profile, can gain protumor characteristics
upon exposure to apoptotic tumor cells. This reprogramming
may reflect the sequence of activation steps undertaken by
TAMs, suggesting a basis for the combined pro- and antitumor
features displayed by SS-TAMs in situ.
Although galectin-3 was rationalized as a promising
candidate molecular player in the modulation of macrophage
activation by apoptotic cells and consequent promotion of
lymphoma growth, we found that it had no part in this process,
at least in our in vitromodel. Rather, our results demonstrated
a novel activity of galectin-3 in macrophage cytotoxicity.
However, NHL growth in mice was substantially inhibited by
global galectin-3 deficiency. Given that galectin-3 appears
largely restricted to SS-TAMs in these tumors (although it
remains possible that galectin-3 expressed at low levels by
tumor cells, and other stromal cells may also contribute), these
results suggest that galectin-3 is closely linked to protumor
functional activation in SS-TAMs. Possible mechanistic
scenarios are summarized in Figure 7. Assuming its main
functional activities in this context are via TAMs, we propose a
dynamic process in which galectin-3 contributes to apoptosis
induced in the tumor cell population by antitumor macrophage
activity. This apoptosis (alongside the consequences of
additional proapoptosis signals to tumor cells, such as nutrient
insufficiency34) leads to conditioning of the antitumor macro-
phages by the apoptotic cells and resultant shift in activation
profile of SS-TAMs to a protumor phenotype. Additional
possible galectin-3 activities in vivo remain to be determined,
but the results obtained thus far provide strong evidence for
targeting galectin-3 in NHL therapy.
In conclusion, although repolarization of TAMs to an
antitumor phenotype provides a plausible route to improving
antitumor therapies, its successful clinical application requires
that the environmental signals to which the macrophage
responds be carefully considered.36 Our results provide a
cautionary note to this approach, indicating that constitutive
apoptosis in the tumor or apoptosis induced by repolarized,
cytotoxic TAMs or by combination radiation or chemotherapy
could militate against therapeutic success by contributing to
what has been aptly termed ‘a misdirected tissue repair
response’.2 Further studies are required to identify the
mechanisms responsible for the reprogramming of cytotoxic
TAMs by apoptotic tumor cells as these could provide critical
therapeutic targets.
Materials and Methods
In situ transcriptomic and bioinformatic analyses. Detailed SS-TAM
and GCM in situ gene expression profiling is described in our previous work.6 In
brief, laser capture microdissection was performed on frozen 10 μm SCID/BL2
tumor xenograft tissue sections stained with CD68-AlexaFluor 488 antibody (Life
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Technologies, Paisley, UK; MCA1957A488) with Protector RNase Inhibitor (4 U/ml;
Roche) or tissue sections of splenic germinal centers from CSF1R EGFP
transgenic BALb/c mice stimulated with two doses of 5 × 106 sheep red blood cells.
Captured cells (1000 cells) were lysed and RNA extracted, amplified and cDNA
synthesized and processed for gene microarray hybridization on Affymetrix
Mouse Gene 1.0 GeneChip arrays (Affymetrix, High Wycombe, UK). Background
subtraction and normalization were performed using the robust multichip average
(RMA) algorithm in the OneChannelGui package. Statistical analysis was conducted
using the LIMMA software Bioconductor (http://www.bioconductor.org) and the
Benjamini and Hochberg procedure was used for multiple testing corrections.
Genes with a corrected P-value o0.05 and an absolute fold change of 1.8 or
greater were considered to be differentially expressed.
Monocyte, macrophage and dendritic cell expression data sets were searched on
the National Center for Biotechnology Information’s GEO (http://www.ncbi.nlm.nih.
gov/geo/). Data sets were selected based on the following criteria: (1) chip platform
(Affymetrix Mouse Gene 1.0 STArray, Affymetrix, High Wycombe, UK), (2) cell type
studied; (3) availability of raw data (.cel) files and (4) availability of at least two
replicates of each cell type within each study. Compatibility of the raw data was
assessed using the arrayQualityMetrics package from Bioconductor. The data were
scored on the basis of seven metrics. Any array suggested to be an outlier on more
than one metric was removed from the data set. Furthermore, data sets that
comprised extra time-points, treatments or knockouts were removed to simplify the
data set. Each remaining data set was then normalized independently, using the RMA
expression measure,37 and any outlier data sets were removed. Probesets of the
microarrays were annotated using the latest annotation available from Bioconductor
(March 2014) to link the AffyIDs to better understandable gene names. Using a
Pearson's threshold cutoff of r= 0.80, a network graph was generated of the data
using BioLayout Express3D (www.biolayout.org).38 Using the MCL algorithm, the
graph was then clustered non-subjectively into clusters of genes that share
similarities in their expression, with the MCL inflation value set to 2.2. For the largest
clusters and other clusters of interest, the gene transcripts were analyzed for
functions using the Functional Annotation Clustering tool on the Database for
Annotation, Visualization, and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.
gov/).39,40 Additionally, genes found to be upregulated by SS-TAMs (compared with
GCMs and lymph node macrophages (LNMs))6 (GEO accession number GSE64366)
were overlaid on the network graph to identify the gene clusters with which they were
associated.
Cells and tumors. BMDMs were prepared from the femurs of 8–24-week-old
Balb/c, C57BL/6 or C57BL/6 Lgals3 KO female mice, and cultured for 7–8 days in
complete RPMI medium (Gibco RPMI-1640; Life Technologies) supplemented with
10% fetal bovine serum (Biosera Ltd, Ringmer, UK), 2 mM L-glutamine
(Life Technologies), 100 U/ml penicillin and 100 μg/ml streptomycin (GE Healthcare
Life Sciences, Buckinghamshire, UK) and 100 ng/ml rhM-CSF (R&D Systems,
Abington, UK) on bacteriological-grade Petri dishes (Sterilin; Fisher Scientific Ltd,
Loughborough, UK). This generated cells that were 497% CD11b and F4/80
positive as measured by flow cytometry. Cells were detached from dishes by
spraying with an 18 g needle and 20 ml syringe. In some in vitro cocultures, BMDMs
were classically activated using 10 U/ml murine IFN-γ (R&D Systems) and 0.5 ng/
ml LPS (Sigma-Alrich, St. Louis MO, USA; (rough strains) from S. enterica serotype
Minnesota Re595) for 4 h before coculture. The human (EBV-negative) BL cell lines
BL2 and BL2-Bcl-2 (BL2 cells stably transfected with Bcl-2 to suppress apoptosis)18
were cultured in suspension in 50% X-VIVO medium (50% Gibco RPMI-1640, 50%
X-VIVO-20 medium; Lonza, Basel, Switzerland), supplemented with 50 U/ml
penicillin and 50 μg/ml streptomycin at 37 °C with 5% CO2. Bcl-2 protein expression
was regularly tested by flow cytometry and498% of the BL2-Bcl-2 cells expressed
Bcl-2. λ-MYC cells were derived and cultured as described.6 Tumors were
generated by subcutaneous injection of 6–12-week-old male C57BL/6 mice (WT or
Lgals3 KO) with 5 × 105 λ-MYC cells. Growth of tumors was monitored using
calipers. In all experiments, mice were humanely killed when tumors reached
dimensions equivalent to 1.44 cm2. All animal procedures and husbandry were
performed under a license from the UK Home Office according to regulations
described in the Animals (Scientific Procedures) Act 1986. For animal studies,
sample sizes were guided by previous experimentation.6
Induction of apoptosis by UV irradiation. Apoptosis was induced by
exposing BL2 or λ-MYC cells in 50% X-VIVO medium to 100 mJ/cm2 of UVB light
using the UVIcab CV006 minicabinet (UVItec Ltd, Cambridge, UK). Following
exposure to UVB, cells were returned to the incubator (37 °C, 5% CO2) for
2 (λ-MYC cells) or 3 h (BL2 cells) before being used in in vitro macrophage-tumor
Figure 7 Schematic outline of possible inter-relationships between macrophages and (apoptotic) lymphoma cells that lead to net tumor growth. Through pathway 1, activity of
highly phagocytic antitumor macrophages (green), typified in these studies by M(IFN-γ/LPS) macrophages, causes apoptosis (2) in lymphoma cells. This displays galectin-3-
dependence. Apoptotic cells in the lymphoma cell population—produced by pathway 1,2 or other mechanisms—are able to condition macrophages (3), at least partially without
the need for direct contact. This apoptotic cell conditioning causes a phenotypic shift in macrophage activation (4) to a tumor-promoting phenotype typical of SS-TAMs which
promote tumor growth (5) via multiple mechanisms as previously described.6 This activity may also be galectin-3-dependent. Other mechanisms through which apoptotic
lymphoma cells promote net tumor growth independently of macrophages may also be important (6). The antitumor activity of macrophages represented here could be inherent in
(certain) TAMs, especially at early stages of tumor development and/or could by induced by macrophage-activating therapies
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cell cocultures or cytotoxicity assays and for 20 h before being used in interaction
and phagocytosis assays. Cell viability was assessed by Annexin V/propidum iodide
(AxV/PI) staining, using AxV-AlexaFluor-488 (Life Technologies; A13201) with the
Attune Acoustic Focusing Cytometer and software (Life Technologies). Alternatively,
cells were fixed in 1% (v/v) formaldehyde (Fisher Scientific Ltd) and stained with
250 ng/ml 4′,6-diamidino-2-phenylindole (DAPI) for 2 h before transferring to a slide
for visualization under UV illumination at × 400 magnification using an Axiovert 25
inverted microscope (Zeiss, Cambridge, UK). Images were recorded with a
DFC425C camera with LASv3.8 software (Leica, Milton Keynes, UK).
Microscopy-based interaction and phagocytosis assay. BL2 or
λ-MYC cells were induced to undergo apoptosis by exposure to UVB irradiation,
followed by a 20 h culture at 37 °C with 5% CO2. Mature BMDMs (40 000 cells)
were added to each well of a glass slide (Hendley, Loughton, Essex, UK) and
incubated for 4 h. After a 20 h incubation, 400 000 UVB-irradiated BL2 cells were
added to each well or media alone was added and the slides were incubated for 1 h
at 37 °C with 5% CO2. For interaction assays, non-adherent cells were washed in
PBS, before fixing the slides in 100% methanol for 20 min. For phagocytosis
assays, washing in PBS was followed by proteolytic removal of apoptotic cells
bound to the macrophage surface with trypsin-EDTA (Fischer Scientific Ltd) for
5 min, and the remaining non-phagocytosed cells were washed off with PBS before
fixation in methanol. Cells were then stained using May–Grünwald–Giemsa. The
number of macrophages interacting with 0, 1 or 2 or more apoptotic cells were then
counted for five randomly chosen areas per well (blinded and duplicate wells for
each treatment) using an Olympus CX40 microscope (Olympus, Southend-on-Sea,
UK), and the mean percentage of macrophages interacting with/phagocytosing
apoptotic cells was calculated. Statistics were performed on biological repeats, that
is, for each n number, BMDMs were derived from a separate animal.
Coculture of macrophages and tumor cells. BMDMs were seeded in
tissue culture plates. BL2, BL2-Bcl-2 or λ-MYC lymphoma cells induced to undergo
apoptosis were added to the macrophages at a 1 : 10 macrophage:lymphoma cell
ratio. In contact-free cocultures, lymphoma cells were placed on top of a 0.44 μm
pore-size Millipore Cell culture plate insert (Sigma-Aldrich). Following a 24 h
coculture, supernatants were collected and cleared by sequential 300xg and
1200 × g centrifugation steps for cytokine analysis. Adherent macrophages were
washed repeatedly with PBS to completely remove the lymphoma cells, before RNA
was extracted using an RNeasy Mini Kit (Qiagen, Manchester, UK).
Cytotoxicity assay. For cytotoxicity assays, macrophage and lymphoma cell
cocultures were performed as detailed above, but BMDMs were stained with PKH67
Green Fluorescent Cell linker dye (Sigma-Aldrich) before seeding in tissue culture
plates in duplicate for each treatment. Following coculture with apoptotic or viable
lymphoma cells, macrophages were cocultured at a 1:1 ratio with new (target) BL2
lymphoma cells taken from fresh cultures and stained with PKH26 red fluorescent
cell membrane dye (Sigma-Aldrich) in 1% X-VIVO medium (1% X-VIVO-20 medium
in 99% Gibco RPMI-1640, supplemented with 100 U/ml penicillin and 100 μg/ml
streptomycin). After a 20 h coculture with target BL2 cells, all cells were dislodged
from the plates by repeated pipetting, stained with F2N12S and SYTOX AADvanced
dead cell stain from the Violet Ratiometric Membrane Asymmetry Probe/Dead Cell
Apoptosis Kit (Life Technologies) and analyzed on the Attune Acoustic Focusing
Cytometer. Compensation was computed using the cytometer’s software. Results
were analyzed as follows: a gate was drawn on the FSC/SSC scatter plot to select
all cells; cells that were positive for PKH67 green fluorescent marker (macrophages)
were subtracted from the total cells; from the remaining cells, red fluorescent-
positive cells were selected (PKH26-labeled target cells) and the ratio of orange
fluorescence versus green fluorescence signal of the F2N12S ratiometric
membrane asymmetry probe was assessed for the target cells only. Statistics
were performed on biological repeats, that is, for each n number, BMDMs were
derived from a separate animal.
Real-time qPCR. Extracted RNA was DNase treated using Amplification Grade
DNase 1 (Sigma-Aldrich), and cDNA was generated from total RNA using
SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Life Technologies).
Real-time qPCR was performed in duplicates in an ABI 7500 FAST qPCR system
using SYBR Green I Dye chemistry (Life Technologies) and gene-specific primers.
Primers were ordered from Eurofins MWG Operon (Ebersberg, Germany) and are
listed in Supplementary Table S1. Relative mRNA expression for genes of interest
was assessed in comparison with control samples, following normalization to the
reference genes α-tubulin (Tuba1b), heat-shock protein 90 (Hsp90), hypoxanthine
guanine phosphoribosyl transferase (Hprt) and β2 microglobulin (B2m) using
the ΔΔCT method (described in Applied Biosystems User Bulletin No. 2
(P/N 4303859)41 in Excel). Appropriateness of reference genes was tested using
NormFinder (version 20).42 The relative quantitation data are presented in graphs
showing log2 expression ratio relative to control samples with error bars
corresponding to the S.E.M. Statistical analysis was performed on the raw (ΔCT)
data for biological replicates, that is, for each n number, BMDMs were derived from
a separate animal.
Histology. Tissue sections were stained with standard hematoxylin and eosin or
were used in immunohistochemistry as described in Truman et al.32 Formalin-fixed,
paraffin-embedded tissue was probed with antibodies to galectin-3 (Bio-Techne,
Oxon, UK; clone M3/38) following heat treatment in citric acid-based antigen
retrieval solution. Immunohistochemical staining was detected using a biotinylated
anti-rat secondary antibody (Vector Laboratories, Peterborough, UK) and
3,3′-diaminobenzidine (Vector Laboratories) with hematoxylin counterstain. Images
were acquired using a Zeiss Axioskop 2 microscope (Carl Zeiss, Cambridge, UK),
with a x20 objective, a Leica DFC425C camera and LASv3.8 software.
Statistical analysis. Results from experiments are presented as individual
data points or means± S.E.M. Data analysis was performed using the GraphPad
Prism version 6 (GraphPad, La Jolla, USA). The following statistical methods were
used on data which were assumed to be normally distributed: two-tailed paired or
unpaired t-test, one-way ANOVA followed by Dunnett’s post test or two-way ANOVA
followed by Tukey’s post test. P-values of 0.05 or less were considered statistically
significant.
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